High-grade Serous Ovarian Cancer (HGSOC) Clinical Trials in Nashville, Tennessee

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors